中国当代医药
中国当代医药杂志欢迎您 今天是   2025年4月15日星期二
设为首页  加入收藏  联系我们         
 
      首 页    |    本刊简介     |    期刊荣誉     |    编采团队     |    会务培训     |    理事单位     |    下载专区     |    在线留言     |    联系我们     |     返回中国当代医药网
中国当代医药  2024, Vol. 31 Issue (15): 77-80转85    
  中医中药 本期目录 | 过刊浏览 | 高级检索 |
左枳六君汤治疗肝胃不和型幽门螺杆菌阳性慢性胃炎的效果
傅 斌 万 军 范 姝 周微红 包奇昌 陈建章 吕燕红 洪建勋
江西中医药高等专科学校附属医院(抚州市中医医院)中医内科,江西抚州 344000
Effect of Zuozhi Liujun Decoction in the treatment of Helicobacter pylori positive chronic gastritis of liver-stomach disharmony type
FU Bin WAN Jun FAN Shu ZHOU Weihong BAO Qichang CHEN Jianzhang LYU Yanhong HONG Jianxun
Department of Traditional Chinese Medicine,Affiliated Hospital of Jiangxi College of Traditional Chinese Medicine(Fuzhou Hospital of Traditional Chinese Medicine),Jiangxi Province,Fuzhou 344000,China
全文: PDF (525 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨左枳六君汤治疗肝胃不和型幽门螺杆菌(Hp)阳性慢性胃炎的效果。方法 选取2021 年1 月至2022 年12 月江西中医药高等专科学校附属医院(抚州市中医医院)收治的70 例慢性胃炎患者(肝胃不和型Hp阳性)作为研究对象,按照随机数字表法分为观察组(35 例)与对照组(35 例),观察组采用常规西药四联治疗+左枳六君汤治疗方法,对照组采用常规西药四联治疗方法。比较两组的临床疗效、中医证候积分、Hp 根除及复发率、血清生化指标。结果 观察组的治疗总有效率(97.15%)、Hp 根除率(94.28%)均高于对照组(82.85%、77.14%),Hp 复发率(2.86%)低于对照组(17.14%),差异有统计学意义(P<0.05)。治疗后,观察组的中医证候积分低于对照组,血清胃泌素、胃动素水平均高于对照组,炎症因子(C 反应蛋白、白介素-6、肿瘤坏死因子-α)水平低于对照组,差异有统计学意义(P<0.05)。结论 在基础对症治疗上,将左枳六君汤引入肝胃不和型Hp 阳性慢性胃炎患者的治疗中,能够提升临床综合治疗效果,作用显著,推荐参考使用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 左枳六君汤肝胃不和幽门螺杆菌慢性胃炎炎症指标    
Abstract:Objective To explore the effect of Zuozhi Liujun Decoction in the treatment of Helicobacter pylori(Hp)positive chronic gastritis of liver-stomach disharmony type.Methods From January 2021 to December 2022,a total of 70 patients with chronic gastritis (Hp positive of liver-stomach disharmony type) admitted to Affiliated Hospital of Jiangxi College of Traditional Chinese Medicine(Fuzhou Hospital of Traditional Chinese Medicine)were selected as the research objects.According to the random number table method,they were divided into observation group(35 cases)and control group(35 cases).The observation group was treated with conventional western medicine quadruple therapy+Zuozhi Liujun Decoction,while the control group was treated with conventional western medicine quadruple therapy.The clinical efficacy,traditional Chinese medicine syndrome score,Hp eradication and recurrence rate,and serum biochemical indexes were compared between the two groups.Results The total effective rate (97.15%)and Hp eradication rate (94.28%)of the observation group were higher than those of the control group(82.85%,77.14%),and the Hp recurrence rate(2.86%)was lower than that of the control group(17.14%),and the differences were statistically significant(P<0.05).After treatment,the traditional Chinese medicine syndrome score of the observation group was lower than that of the control group,the levels of serum gastrin and motilin were higher than those of the control group,and the levels of inflammatory factors(C-reactive protein,interleukin-6,tumor necrosis factor-α)were lower than those of the control group,and the differences were statistically significant (P<0.05).Conclusion On the basis of symptomatic treatment,the introduction of Zuozhi Liujun Decoction into the treatment of patients with liver-stomach disharmony type Hp positive chronic gastritis can improve the clinical comprehensive treatment effect,and the effect is significant,so it is recommended for reference.
Key wordsZuozhi Liujun Decoction    Liver-stomach disharmony    Helicobacter pylori    Chronic gastritis    Inflammatory indicators
    
基金资助:全国名老中医药专家传承工作室建设项目(国中医药办人教函〔2022〕75 号);江西省教育厅科学技术研究项目(GJJ2205911)。
引用本文:   
傅 斌; 万 军; 范 姝; 周微红; 包奇昌; 陈建章; 吕燕红; 洪建勋. 左枳六君汤治疗肝胃不和型幽门螺杆菌阳性慢性胃炎的效果[J]. 中国当代医药, 2024, 31(15): 77-80转85.
FU Bin WAN Jun FAN Shu ZHOU Weihong BAO Qichang CHEN Jianzhang LYU Yanhong HONG Jianxun. Effect of Zuozhi Liujun Decoction in the treatment of Helicobacter pylori positive chronic gastritis of liver-stomach disharmony type. 中国当代医药, 2024, 31(15): 77-80转85.
链接本文:  
https://www.dangdaiyiyao.com/CN/     或     https://www.dangdaiyiyao.com/CN/Y2024/V31/I15/77
中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP备11001767号-6  京公网安备 11010502046607号  互联网药品信息服务资格证  期刊出版许可证  广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626690 总机:010-59626692/18/19/20   传真:010-59626204   投稿信箱:ddyy@vip.163.com
地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室   邮编:100124
技术支持:北京玛格泰克科技发展有限公司
Copyright 2000-2014 版权所有 《中国当代医药》杂志社 未经授权请勿转载